# MPLT (MapLight Therapeutics, Inc.) - SEC EDGAR Financial Statements

> MapLight Therapeutics, Inc. reported $477.2M in total assets and a net loss of $252.0M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/MPLT
- Markdown: https://convexityos.com/fundamentals/MPLT.md
- SEC CIK: 0001770069
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:40 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001770069&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$266.8M | Operating profit |
| Net Income | FY 2025 | -$252.0M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$4.75 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$138.6M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $284.1M | Total debt: $1.69M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Research & Development | $138.3M | $68.52M |
| Total Operating Expenses | $169.1M | $82.95M |
| **Operating Income** | -$169.1M | -$82.95M |
| **EBITDA** | -$168.5M | -$82.25M |
| Interest Income | $5.52M | $4.50M |
| **Net Income** | -$161.2M | -$77.58M |
| Basic EPS | -$18.56 | -$105.38 |
| **Diluted EPS** | -$18.56 | -$105.38 |
| Basic Shares Outstanding | 8.7M | 736.2K |
| Diluted Shares Outstanding | 8.7M | 736.2K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $44.21M | $53.44M | $53.68M | $64.62M | $27.09M | $26.85M | $19.79M | -- |
| Total Operating Expenses | $55.34M | $63.55M | $64.50M | $83.38M | $31.50M | $30.66M | $23.54M | -- |
| **Operating Income** | -$55.34M | -$63.55M | -$64.50M | -$83.38M | -$31.50M | -$30.66M | -$23.54M | -- |
| **EBITDA** | -$55.21M | -$63.40M | -$64.34M | -$83.24M | -$31.40M | -$30.53M | -$23.38M | -- |
| Interest Income | $3.09M | $2.35M | $2.47M | $2.47M | $1.55M | $688K | $811K | -- |
| **Net Income** | -$51.62M | -$60.19M | -$60.67M | -$79.55M | -$29.42M | -$29.84M | -$22.34M | -$21.23M |
| Basic EPS | -$0.97 | -$1.32 | -$1.34 | -- | -$37.18 | -$39.11 | -$29.33 | -- |
| **Diluted EPS** | -$0.97 | -$1.32 | -$1.34 | -- | -$37.18 | -$39.11 | -$29.33 | -- |
| Basic Shares Outstanding | 53.1M | 45.4M | 45.3M | -- | 791.1K | 763.0K | 761.6K | -- |
| Diluted Shares Outstanding | 53.1M | 45.4M | 45.3M | -- | 791.1K | 763.0K | 761.6K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $46.73M | $38.25M |
| Short-Term Investments | $258.4M | $70.54M |
| **Cash & Short-Term Investments** | $453.1M | $108.8M |
| **Total Current Assets** | $324.7M | $114.6M |
| Property, Plant & Equipment, Net | $1.09M | $1.21M |
| Long-Term Investments | $148.0M | $11.38M |
| Other Non-Current Assets | $59K | $3.17M |
| **Total Non-Current Assets** | $154.8M | $22.31M |
| **Total Assets** | $479.5M | $136.9M |
| Accounts Payable | $3.29M | $1.91M |
| Deferred Revenue (Current) | $0 | $3.24M |
| **Total Current Liabilities** | $16.23M | $15.92M |
| **Total Non-Current Liabilities** | $4.91M | $5.80M |
| **Total Liabilities** | $21.14M | $21.72M |
| **Total Debt (incl. Leases)** | $5.80M | $6.58M |
| Common Stock | $5.0K | $0 |
| Retained Earnings | -$360.5M | -$199.4M |
| Accumulated Other Comp. Income | -$228K | $163K |
| **Total Stockholders' Equity** | $458.4M | -$193.6M |
| Total Equity | $458.4M | -$193.6M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $55.57M | $71.63M | $55.71M | $46.73M | $64.15M | $38.25M |
| Short-Term Investments | $228.5M | $233.1M | $254.4M | $258.4M | $163.0M | $70.54M |
| **Cash & Short-Term Investments** | $284.1M | $304.7M | $310.1M | $453.1M | $227.2M | $108.8M |
| **Total Current Assets** | $294.6M | $318.8M | $327.2M | $324.7M | $245.3M | $114.6M |
| Property, Plant & Equipment, Net | $722K | $828K | $968K | $1.09M | $859K | $1.21M |
| Long-Term Investments | $179.3M | $46.62M | $85.09M | $148.0M | -- | $11.38M |
| Other Non-Current Assets | $14K | $241K | $36K | $59K | $5.14M | $3.17M |
| **Total Non-Current Assets** | $182.6M | $49.56M | $91.56M | $154.8M | $11.92M | $22.31M |
| **Total Assets** | $477.2M | $368.3M | $418.8M | $479.5M | $257.2M | $136.9M |
| Accounts Payable | $2.96M | $2.05M | $3.19M | $3.29M | $2.45M | $1.91M |
| Deferred Revenue (Current) | -- | -- | $0 | $0 | $1.21M | $3.24M |
| **Total Current Liabilities** | $30.90M | $19.29M | $14.28M | $16.23M | $18.56M | $15.92M |
| **Total Non-Current Liabilities** | $510K | $755K | $4.67M | $4.91M | $5.14M | $5.80M |
| **Total Liabilities** | $31.41M | $20.05M | $18.95M | $21.14M | $23.71M | $21.72M |
| **Total Debt (incl. Leases)** | $1.69M | $1.99M | $5.59M | $5.80M | $6.01M | $6.58M |
| Common Stock | $6.0K | $5.0K | $5.0K | $5.0K | $0 | $0 |
| Retained Earnings | -$533.0M | -$481.4M | -$421.2M | -$360.5M | -$281.0M | -$199.4M |
| Accumulated Other Comp. Income | -$3.01M | -$944K | -$883K | -$228K | $46K | $163K |
| **Total Stockholders' Equity** | $445.8M | $348.3M | $399.8M | $458.4M | -$274.2M | -$193.6M |
| Total Equity | $445.8M | $348.3M | $399.8M | $458.4M | -$274.2M | -$193.6M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Net Income | -$161.2M | -$77.58M |
| Depreciation & Amortization | $578K | $701K |
| Stock-Based Compensation | $36.01M | $1.08M |
| Change in Payables | $1.38M | -$1.34M |
| **Operating Cash Flow** | -$138.1M | -$78.81M |
| Capital Expenditure | -$473K | -$770K |
| **Free Cash Flow** | -$138.6M | -$79.58M |
| Purchases of Investments | -$408.2M | -$125.0M |
| **Investing Cash Flow** | -$323.2M | -$80.79M |
| **Financing Cash Flow** | $469.8M | $118.1M |
| **Net Change in Cash** | $8.48M | -$41.54M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$51.62M | -$60.19M | -$60.67M | -$79.55M | -$29.42M | -$29.84M | -$22.34M | -$21.23M |
| Depreciation & Amortization | $135K | $147K | $162K | $140K | $100K | $136K | $166K | -- |
| Stock-Based Compensation | $10.26M | $8.63M | $9.64M | $35.52M | $125K | $148K | $212K | -- |
| Change in Payables | $894K | -$1.13M | -$111K | $893K | $301K | $1.24M | -$1.05M | -- |
| **Operating Cash Flow** | -$35.68M | -$44.87M | -$51.18M | -$46.83M | -$31.79M | -$33.97M | -$25.55M | -- |
| Capital Expenditure | -$12K | -$22K | -$24K | -- | -- | -- | -- | -- |
| **Free Cash Flow** | -$35.69M | -$44.89M | -$51.20M | -- | -- | -- | -- | -- |
| Sales & Maturities of Investments | $59.75M | $80.50M | $67.03M | -- | $6.50M | $17.50M | $37.50M | -- |
| **Investing Cash Flow** | -$130.1M | $60.70M | $67.01M | -$242.6M | -$135.6M | $17.43M | $37.50M | -- |
| **Financing Cash Flow** | $150.5M | $92K | -$6.85M | $272.0M | $198.1M | -$156K | -$47K | -- |
| **Net Change in Cash** | -$15.20M | $15.93M | $8.98M | -$17.42M | $30.68M | -$16.69M | $11.90M | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Return on Equity (ROE) | -35.2% | -- |
| Return on Assets (ROA) | -33.6% | -56.7% |
| Current Ratio | 20.01x | 7.20x |
| Quick Ratio | 27.92x | 6.83x |
| Debt to Equity | 0.01x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -56.5% | -66.0% | -49.9% | -35.2% | -- | -- | -- | -- |
| Return on Assets (ROA) | -52.8% | -62.4% | -47.6% | -33.6% | -40.0% | -- | -- | -56.7% |
| Current Ratio | 9.53x | 16.52x | 22.91x | 20.01x | 13.22x | -- | -- | 7.20x |
| Quick Ratio | 9.19x | 15.79x | 21.71x | 27.92x | 12.24x | -- | -- | 6.83x |
| Debt to Equity | 0.00x | 0.01x | 0.01x | 0.01x | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
